Hamad Abdel Hadi

850 total citations
47 papers, 487 citations indexed

About

Hamad Abdel Hadi is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology and Molecular Medicine. According to data from OpenAlex, Hamad Abdel Hadi has authored 47 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 17 papers in Applied Microbiology and Biotechnology and 16 papers in Molecular Medicine. Recurrent topics in Hamad Abdel Hadi's work include Antibiotic Use and Resistance (17 papers), Antibiotic Resistance in Bacteria (16 papers) and COVID-19 Clinical Research Studies (8 papers). Hamad Abdel Hadi is often cited by papers focused on Antibiotic Use and Resistance (17 papers), Antibiotic Resistance in Bacteria (16 papers) and COVID-19 Clinical Research Studies (8 papers). Hamad Abdel Hadi collaborates with scholars based in Qatar, United States and Sweden. Hamad Abdel Hadi's co-authors include Ali A. Sultan, Sini Skariah, Devendra Bansal, Nahla O. Eltai, Elmoubasher Farag, Md. Mazharul Islam, Chris R. Triggle, Hong Ding, Emad Bashir Ibrahim and Hashim Alhussain and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Frontiers in Immunology.

In The Last Decade

Hamad Abdel Hadi

38 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hamad Abdel Hadi Qatar 11 201 200 163 97 78 47 487
Eimear Brannigan United Kingdom 13 235 1.2× 187 0.9× 143 0.9× 117 1.2× 102 1.3× 24 536
Ghada Ismail Egypt 9 159 0.8× 152 0.8× 93 0.6× 117 1.2× 68 0.9× 28 489
Toshiki Kajihara Japan 13 127 0.6× 102 0.5× 139 0.9× 127 1.3× 85 1.1× 34 454
Irna Carla do Rosário Souza Carneiro Brazil 9 165 0.8× 120 0.6× 151 0.9× 110 1.1× 82 1.1× 23 455
Aki Hirabayashi Japan 15 238 1.2× 119 0.6× 101 0.6× 126 1.3× 110 1.4× 39 543
Reena Raveendran India 11 234 1.2× 146 0.7× 227 1.4× 243 2.5× 54 0.7× 22 560
Mostafa Elouennass Morocco 13 248 1.2× 88 0.4× 136 0.8× 164 1.7× 109 1.4× 90 568
Siddharth Mookerjee United Kingdom 10 178 0.9× 102 0.5× 118 0.7× 73 0.8× 53 0.7× 14 329
Ícaro Boszczowski Brazil 14 199 1.0× 160 0.8× 84 0.5× 112 1.2× 30 0.4× 40 550
Mark Supino United States 6 163 0.8× 234 1.2× 90 0.6× 180 1.9× 81 1.0× 11 660

Countries citing papers authored by Hamad Abdel Hadi

Since Specialization
Citations

This map shows the geographic impact of Hamad Abdel Hadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamad Abdel Hadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamad Abdel Hadi more than expected).

Fields of papers citing papers by Hamad Abdel Hadi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamad Abdel Hadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamad Abdel Hadi. The network helps show where Hamad Abdel Hadi may publish in the future.

Co-authorship network of co-authors of Hamad Abdel Hadi

This figure shows the co-authorship network connecting the top 25 collaborators of Hamad Abdel Hadi. A scholar is included among the top collaborators of Hamad Abdel Hadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamad Abdel Hadi. Hamad Abdel Hadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hadi, Hamad Abdel, et al.. (2024). Antimicrobial Resistance in Qatar: Prevalence and Trends before and Amidst the COVID-19 Pandemic. Antibiotics. 13(3). 203–203. 2 indexed citations
2.
3.
Ibrahim, Emad Bashir, et al.. (2024). Phenotypic and Genotypic Characterization of Pan-Drug-Resistant Klebsiella pneumoniae Isolated in Qatar. Antibiotics. 13(3). 275–275. 5 indexed citations
4.
Aboukamar, Mohamed, et al.. (2023). Evaluation of anakinra in the management of patients with COVID-19 infection: A randomized clinical trial. Frontiers in Microbiology. 14. 1098703–1098703. 5 indexed citations
5.
6.
Abdelrahman, Hisham A., et al.. (2023). Wastewater-based epidemiology for tracking bacterial diversity and antibiotic resistance in COVID-19 isolation hospitals in Qatar. Journal of Hospital Infection. 141. 209–220. 8 indexed citations
7.
Hadi, Hamad Abdel, et al.. (2022). Dilemma of Tocilizumab therapy for a patient with critical COVID‐19 disease and neutropenia: Case report and review of the literature. SHILAP Revista de lepidopterología. 10(5). e05932–e05932. 2 indexed citations
8.
Hadi, Hamad Abdel, et al.. (2022). Remdesivir for COVID‐19 pneumonia in patients with severe chronic kidney disease: A Case series and review of the literature. SHILAP Revista de lepidopterología. 10(2). e05467–e05467. 4 indexed citations
9.
10.
Alhussain, Hashim, et al.. (2021). The Spectrum of Antibiotic Prescribing During COVID-19 Pandemic: A Systematic Literature Review. Microbial Drug Resistance. 27(12). 1705–1725. 41 indexed citations
11.
Ibrahim, Emad Bashir, et al.. (2021). Central line‐associated Rhodotorula mucilaginosa fungemia in an immunocompetent host: Case report and review of the literature. SHILAP Revista de lepidopterología. 9(4). 2158–2161. 9 indexed citations
12.
Ibrahim, Emad Bashir, et al.. (2021). Ominous combination: COVID‐19 disease and Candida auris fungemia—Case report and review of the literature. SHILAP Revista de lepidopterología. 9(9). e04827–e04827. 11 indexed citations
13.
Alhussain, Hashim, et al.. (2021). Antibiotics Prescribing in Intensive Care Settings during the COVID-19 Era: A Systematic Review. Antibiotics. 10(8). 935–935. 31 indexed citations
14.
Hadi, Hamad Abdel, et al.. (2021). Beware of the ambiguous enemy of multisystem inflammatory syndrome in adult (MIS‐A) following Covid‐19 infection or vaccination. SHILAP Revista de lepidopterología. 9(11). 6 indexed citations
15.
Al‐Bozom, Issam, et al.. (2021). Schistosoma gallbladder polyp masquerading as a neoplasm: Rare case report and literature review. SHILAP Revista de lepidopterología. 9(7). e04420–e04420. 2 indexed citations
16.
Husain, Ahmed, Hamad Abdel Hadi, Sini Skariah, et al.. (2021). Clinical outcomes, molecular epidemiology and resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa isolated from bloodstream infections from Qatar. Annals of Medicine. 53(1). 2345–2353. 6 indexed citations
17.
Hadi, Hamad Abdel, et al.. (2021). Epidemiology of Multidrug-Resistant Pseudomonas aeruginosa in the Middle East and North Africa Region. mSphere. 6(3). 81 indexed citations
18.
Wani, Mohd Lateef, et al.. (2021). Challenges in the diagnosis of pulmonary mucormycosis in a diabetic with a review of literature. Respiratory Medicine Case Reports. 33. 101474–101474. 2 indexed citations
19.
Petkar, Mahir, et al.. (2020). Ancient foe spectra: Case series of Mycobacterium tuberculosis presentations. SHILAP Revista de lepidopterología. 9(2). 714–717. 1 indexed citations
20.
Clarke, Carl E, Pinak Ray, & Hamad Abdel Hadi. (1999). An adolescent Pakistani girl with chronic meningitis. Postgraduate Medical Journal. 75(879). 47–49. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eimear Brannigan Breakdown of academic impact, for papers by Ghada Ismail Breakdown of academic impact, for papers by Toshiki Kajihara Breakdown of academic impact, for papers by Irna Carla do Rosário Souza Carneiro Breakdown of academic impact, for papers by Aki Hirabayashi Breakdown of academic impact, for papers by Reena Raveendran Breakdown of academic impact, for papers by Mostafa Elouennass Breakdown of academic impact, for papers by Siddharth Mookerjee Breakdown of academic impact, for papers by Ícaro Boszczowski Breakdown of academic impact, for papers by Mark Supino
Rankless by CCL
2026